234 related articles for article (PubMed ID: 21524885)
1. β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome.
Blank M; Baraam L; Eisenstein M; Fridkin M; Dardik R; Heldman Y; Katchalski-Katzir E; Shoenfeld Y
J Autoimmun; 2011 Aug; 37(1):8-17. PubMed ID: 21524885
[TBL] [Abstract][Full Text] [Related]
2. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
4. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.
Blank M; Krause I; Fridkin M; Keller N; Kopolovic J; Goldberg I; Tobar A; Shoenfeld Y
J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188
[TBL] [Abstract][Full Text] [Related]
5. Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome.
Blank M; George J; Barak V; Tincani A; Koike T; Shoenfeld Y
J Immunol; 1998 Nov; 161(10):5303-12. PubMed ID: 9820503
[TBL] [Abstract][Full Text] [Related]
6. Both NF-κB and c-Jun/AP-1 involved in anti-β2GPI/β2GPI-induced tissue factor expression in monocytes.
Xia L; Zhou H; Hu L; Xie H; Wang T; Xu Y; Liu J; Zhang X; Yan J
Thromb Haemost; 2013 Apr; 109(4):643-51. PubMed ID: 23467542
[TBL] [Abstract][Full Text] [Related]
7. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
Yasuda S; Atsumi T; Ieko M; Koike T
Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
[TBL] [Abstract][Full Text] [Related]
8. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid syndrome: 30 years and our contribution.
Koike T
Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
[TBL] [Abstract][Full Text] [Related]
10. Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.
Kuwana M
Thromb Res; 2004; 114(5-6):347-55. PubMed ID: 15507264
[TBL] [Abstract][Full Text] [Related]
11. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection.
Blank M; Shani A; Goldberg I; Kopolovic J; Amigo MC; Magrini L; Shoenfeld Y
Thromb Res; 2004; 114(5-6):589-92. PubMed ID: 15507295
[TBL] [Abstract][Full Text] [Related]
12. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
Sheng Y; Kandiah DA; Krilis SA
J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
[TBL] [Abstract][Full Text] [Related]
14. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
Ostertag MV; Liu X; Henderson V; Pierangeli SS
Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression.
Agmon-Levin N; Blank M; Zandman-Goddard G; Orbach H; Meroni PL; Tincani A; Doria A; Cervera R; Miesbach W; Stojanovich L; Barak V; Porat-Katz BS; Amital H; Shoenfeld Y
Ann Rheum Dis; 2011 Jan; 70(1):145-50. PubMed ID: 20980705
[TBL] [Abstract][Full Text] [Related]
16. Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway.
Betapudi V; Lominadze G; Hsi L; Willard B; Wu M; McCrae KR
Blood; 2013 Nov; 122(23):3808-17. PubMed ID: 23954892
[TBL] [Abstract][Full Text] [Related]
17. [Activation of tumor necrosis factor receptor-associated factor 6 in anti-β2GPI/β2GPI-induced tissue factor expression on THP-1 cells].
Xu GY; Zhou H; Wen HP; Guo DL; Zhou F; Chen DD; Xie HX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 May; 27(5):487-90. PubMed ID: 21557901
[TBL] [Abstract][Full Text] [Related]
18. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
Pierangeli SS; Harris EN
Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
[TBL] [Abstract][Full Text] [Related]
19. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
[TBL] [Abstract][Full Text] [Related]
20. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo.
Pierangeli SS; Blank M; Liu X; Espinola R; Fridkin M; Ostertag MV; Roye-Green K; Harris EN; Shoenfeld Y
J Autoimmun; 2004 May; 22(3):217-25. PubMed ID: 15041042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]